First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients

Aim. To evaluate the predictive value of RRM1, ERCCl, and BRCA1 expression in Chinese NSCLC patients treated with gemcitabine and cisplatin. Methods. Real-time fluorescent quantitative PCR was used to determine the RRM1, ERCC1, and BRCA1 mRNA expression levels of peripheral blood in late-stage NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Wang, Lin Run, Chen, Jian, Lou, Yan, Zhang, Guo Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925578/
https://www.ncbi.nlm.nih.gov/pubmed/24591771
http://dx.doi.org/10.1155/2014/960458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925578/
https://www.ncbi.nlm.nih.gov/pubmed/24591771
http://dx.doi.org/10.1155/2014/960458

Ejemplares similares